PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Chest Medicine, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.\', \'Institute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung, Taiwan; Department of Pharmacy, E-Da Hospital, Kaohsiung, Taiwan.\', \'Division of Chest Medicine, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan; Department of Critical Care Medicine, E-Da Hospital, Kaohsiung, Taiwan.\', \'Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan.\', \'Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan. Electronic address: dtmed141@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1567-5769(21)00663-910.1016/j.intimp.2021.108027
?:doi
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34343937
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
?:title
  • Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all